Position in RPRX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,630
New position
Shares Held
34
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Mar 31, 2026MidFirst Bank holds $138,768 across 12 Biotechnology names. RPRX ranks #7 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
96 | $74,173 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
110 | $49,119 | |
| 3 | TECH |
BIO-TECHNE Corp
|
61 | $3,187 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
47 | $3,037 | |
| 5 | GMAB |
Genmab A/S
|
75 | $2,012 | |
| 6 | FLNA |
Filana Therapeutics, Inc.
|
1,000 | $1,690 | |
| 7 | RPRX |
Royalty Pharma plc
This page
|
34 | $1,630 | |
| 8 | EXEL |
Exelixis, Inc.
|
30 | $1,286 |
All Filings in RPRX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,630 | 34 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||